Reliance Life Sciences to unveil 4 follow-on biologics in 2010

03/30/2009 | Business Standard (India)

Reliance Life Sciences is conducting clinical trials of four follow-on biologics, which are aimed at oncology and cardiology markets, and plans to introduce the drugs next year. The Indian company, which unveiled three biosimilars in 2008, plans to market its treatments in the U.S. and Europe once a regulatory pathway for such products transpires, a company official said.

View Full Article in:

Business Standard (India)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Accreditation
Meridian Health Plan
Detroit, MI
Stop Loss Sales Executive, (Southern Region)
Indigo Insurance Services
Multiple Locations, SL_Multiple Locations
Chief Executive Officer
Center for Improving Value in Healthcare
Denver, CO
Quality Program Manager II, State Programs
Tufts Health Plan
Watertown, MA
Senior director risk adjustor and coding doc
Novant Health
Charlotte, NC